公开(公告)号：US20180064682A1

公开(公告)日：2018-03-08

申请号：US15798530

申请日：2017-10-31

Applicant: Yeda Research and Development Co. Ltd.

Inventor： Menachem RUBINSTEIN ,  Efrat DVASH-RIESENFELD

IPC: A61K31/366 ,  A61K31/381 ,  A61K31/41

Abstract: The present invention relates to the alleviation of adverse side effects resulting from statin therapy. The present invention further relates to the use of an inhibitor of leukotriene C4 (LTC4) mediated activity for alleviating at least one side effects of statin therapy.

公开(公告)号：US20170172979A1

公开(公告)日：2017-06-22

申请号：US15118196

申请日：2015-02-18

Applicant: Yeda Research and Development Co. Ltd.

Inventor： Menachem RUBINSTEIN ,  Efrat DVASH-RIESENFELD

IPC: A61K31/366 ,  A61K31/381 ,  A61K31/41

CPC classification number: A61K31/366 ,  A61K31/166 ,  A61K31/192 ,  A61K31/381 ,  A61K31/404 ,  A61K31/41 ,  A61K31/426 ,  A61K31/47 ,  A61K2300/00

Abstract: The present invention relates to the alleviation of adverse side effects resulting from statin therapy. The present invention further relates to the use of an inhibitor of leukotriene C4 (LTC4) mediated activity for alleviating at least one side effects of statin therapy.